Accordingly that, pathway enrichment analysis using EnrichR19 showed that in both MCF-7 and HCC1395, genes with negative 3D-2D ß-score were enriched for genes that have MYC interacting with their promoter in both mouse embryonic stem cells (mESCs) or BC cells (Fig. S1a, d). The gene discussed is MYC; the disease is breast cancer.